These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Immune control in hepatocellular carcinoma development and progression: role of stromal cells. Sprinzl MF; Galle PR Semin Liver Dis; 2014 Nov; 34(4):376-88. PubMed ID: 25369300 [TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive cells in tumor immune escape and metastasis. Liu Y; Cao X J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709 [TBL] [Abstract][Full Text] [Related]
37. Crosstalk between cancer and immune cells: Role of tumor-associated macrophages in the tumor microenvironment. Wang J; Li D; Cang H; Guo B Cancer Med; 2019 Aug; 8(10):4709-4721. PubMed ID: 31222971 [TBL] [Abstract][Full Text] [Related]
38. Targeting regulatory T cells in tumors. Liu C; Workman CJ; Vignali DA FEBS J; 2016 Jul; 283(14):2731-48. PubMed ID: 26787424 [TBL] [Abstract][Full Text] [Related]
39. Overview of Basic Immunology for Clinical Investigators. Stephen B; Hajjar J Adv Exp Med Biol; 2017; 995():1-31. PubMed ID: 28321810 [TBL] [Abstract][Full Text] [Related]
40. High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy. Kalathil SG; Thanavala Y Cancer Immunol Immunother; 2016 Jul; 65(7):813-9. PubMed ID: 26910314 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]